REPORT ID 407

Global Irritable Bowel Syndrome Treatment Sales Market Report 2017

Publish Date
01-Dec-17
Pages
104
Format
Electronic (PDF)

In this report, the global Irritable Bowel Syndrome Treatment market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split global into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Irritable Bowel Syndrome Treatment for these regions, from 2012 to 2022 (forecast), covering
    United States
    China
    Europe
    Japan
    Southeast Asia
    India

Global Irritable Bowel Syndrome Treatment market competition by top manufacturers/players, with Irritable Bowel Syndrome Treatment sales volume, Price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including
    Abbott Laboratories
    Synergy Pharmaceuticals, Inc.
    Sucampo Pharmaceuticals, Inc.
    Valeant Pharmaceuticals International, Inc.
    Ardelyx, Inc.
    Astellas Pharma Inc.
    Novartis AG
    GlaxoSmithKline plc.
    Ironwood Pharmaceuticals, Inc.
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Lubiprostone
    Linaclotide
    Eluxadoline
    Rifaximin
    Ramosetron Hydrochloride
    Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Hospital
    Clinic
    Home Care

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Global Irritable Bowel Syndrome Treatment Sales Market Report 2017
1 Irritable Bowel Syndrome Treatment Market Overview
    1.1 Product Overview and Scope of Irritable Bowel Syndrome Treatment
    1.2 Classification of Irritable Bowel Syndrome Treatment by Product Category
        1.2.1 Global Irritable Bowel Syndrome Treatment Market Size (Sales) Comparison by Type (2012-2022)
        1.2.2 Global Irritable Bowel Syndrome Treatment Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 Lubiprostone
        1.2.4 Linaclotide
        1.2.5 Eluxadoline
        1.2.6 Rifaximin
        1.2.7 Ramosetron Hydrochloride
        1.2.8 Others
    1.3 Global Irritable Bowel Syndrome Treatment Market by Application/End Users
        1.3.1 Global Irritable Bowel Syndrome Treatment Sales (Volume) and Market Share Comparison by Application (2012-2022)
        1.3.2 Hospital
        1.3.3 Clinic
        1.3.4 Home Care
    1.4 Global Irritable Bowel Syndrome Treatment Market by Region
        1.4.1 Global Irritable Bowel Syndrome Treatment Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 United States Irritable Bowel Syndrome Treatment Status and Prospect (2012-2022)
        1.4.3 China Irritable Bowel Syndrome Treatment Status and Prospect (2012-2022)
        1.4.4 Europe Irritable Bowel Syndrome Treatment Status and Prospect (2012-2022)
        1.4.5 Japan Irritable Bowel Syndrome Treatment Status and Prospect (2012-2022)
        1.4.6 Southeast Asia Irritable Bowel Syndrome Treatment Status and Prospect (2012-2022)
        1.4.7 India Irritable Bowel Syndrome Treatment Status and Prospect (2012-2022)
    1.5 Global Market Size (Value and Volume) of Irritable Bowel Syndrome Treatment (2012-2022)
        1.5.1 Global Irritable Bowel Syndrome Treatment Sales and Growth Rate (2012-2022)
        1.5.2 Global Irritable Bowel Syndrome Treatment Revenue and Growth Rate (2012-2022)

2 Global Irritable Bowel Syndrome Treatment Competition by Players/Suppliers, Type and Application
     2.1 Global Irritable Bowel Syndrome Treatment Market Competition by Players/Suppliers
        2.1.1 Global Irritable Bowel Syndrome Treatment Sales and Market Share of Key Players/Suppliers (2012-2017)
        2.1.2 Global Irritable Bowel Syndrome Treatment Revenue and Share by Players/Suppliers (2012-2017)
    2.2 Global Irritable Bowel Syndrome Treatment (Volume and Value) by Type
        2.2.1 Global Irritable Bowel Syndrome Treatment Sales and Market Share by Type (2012-2017)
        2.2.2 Global Irritable Bowel Syndrome Treatment Revenue and Market Share by Type (2012-2017)
    2.3 Global Irritable Bowel Syndrome Treatment (Volume and Value) by Region
        2.3.1 Global Irritable Bowel Syndrome Treatment Sales and Market Share by Region (2012-2017)
        2.3.2 Global Irritable Bowel Syndrome Treatment Revenue and Market Share by Region (2012-2017)
    2.4 Global Irritable Bowel Syndrome Treatment (Volume) by Application

3 United States Irritable Bowel Syndrome Treatment (Volume, Value and Sales Price)
    3.1 United States Irritable Bowel Syndrome Treatment Sales and Value (2012-2017)
        3.1.1 United States Irritable Bowel Syndrome Treatment Sales and Growth Rate (2012-2017)
        3.1.2 United States Irritable Bowel Syndrome Treatment Revenue and Growth Rate (2012-2017)
        3.1.3 United States Irritable Bowel Syndrome Treatment Sales Price Trend (2012-2017)
    3.2 United States Irritable Bowel Syndrome Treatment Sales Volume and Market Share by Players
    3.3 United States Irritable Bowel Syndrome Treatment Sales Volume and Market Share by Type
    3.4 United States Irritable Bowel Syndrome Treatment Sales Volume and Market Share by Application

4 China Irritable Bowel Syndrome Treatment (Volume, Value and Sales Price)
    4.1 China Irritable Bowel Syndrome Treatment Sales and Value (2012-2017)
        4.1.1 China Irritable Bowel Syndrome Treatment Sales and Growth Rate (2012-2017)
        4.1.2 China Irritable Bowel Syndrome Treatment Revenue and Growth Rate (2012-2017)
        4.1.3 China Irritable Bowel Syndrome Treatment Sales Price Trend (2012-2017)
    4.2 China Irritable Bowel Syndrome Treatment Sales Volume and Market Share by Players
    4.3 China Irritable Bowel Syndrome Treatment Sales Volume and Market Share by Type
    4.4 China Irritable Bowel Syndrome Treatment Sales Volume and Market Share by Application

5 Europe Irritable Bowel Syndrome Treatment (Volume, Value and Sales Price)
    5.1 Europe Irritable Bowel Syndrome Treatment Sales and Value (2012-2017)
        5.1.1 Europe Irritable Bowel Syndrome Treatment Sales and Growth Rate (2012-2017)
        5.1.2 Europe Irritable Bowel Syndrome Treatment Revenue and Growth Rate (2012-2017)
        5.1.3 Europe Irritable Bowel Syndrome Treatment Sales Price Trend (2012-2017)
    5.2 Europe Irritable Bowel Syndrome Treatment Sales Volume and Market Share by Players
    5.3 Europe Irritable Bowel Syndrome Treatment Sales Volume and Market Share by Type
    5.4 Europe Irritable Bowel Syndrome Treatment Sales Volume and Market Share by Application

6 Japan Irritable Bowel Syndrome Treatment (Volume, Value and Sales Price)
    6.1 Japan Irritable Bowel Syndrome Treatment Sales and Value (2012-2017)
        6.1.1 Japan Irritable Bowel Syndrome Treatment Sales and Growth Rate (2012-2017)
        6.1.2 Japan Irritable Bowel Syndrome Treatment Revenue and Growth Rate (2012-2017)
        6.1.3 Japan Irritable Bowel Syndrome Treatment Sales Price Trend (2012-2017)
    6.2 Japan Irritable Bowel Syndrome Treatment Sales Volume and Market Share by Players
    6.3 Japan Irritable Bowel Syndrome Treatment Sales Volume and Market Share by Type
    6.4 Japan Irritable Bowel Syndrome Treatment Sales Volume and Market Share by Application

7 Southeast Asia Irritable Bowel Syndrome Treatment (Volume, Value and Sales Price)
    7.1 Southeast Asia Irritable Bowel Syndrome Treatment Sales and Value (2012-2017)
        7.1.1 Southeast Asia Irritable Bowel Syndrome Treatment Sales and Growth Rate (2012-2017)
        7.1.2 Southeast Asia Irritable Bowel Syndrome Treatment Revenue and Growth Rate (2012-2017)
        7.1.3 Southeast Asia Irritable Bowel Syndrome Treatment Sales Price Trend (2012-2017)
    7.2 Southeast Asia Irritable Bowel Syndrome Treatment Sales Volume and Market Share by Players
    7.3 Southeast Asia Irritable Bowel Syndrome Treatment Sales Volume and Market Share by Type
    7.4 Southeast Asia Irritable Bowel Syndrome Treatment Sales Volume and Market Share by Application

8 India Irritable Bowel Syndrome Treatment (Volume, Value and Sales Price)
    8.1 India Irritable Bowel Syndrome Treatment Sales and Value (2012-2017)
        8.1.1 India Irritable Bowel Syndrome Treatment Sales and Growth Rate (2012-2017)
        8.1.2 India Irritable Bowel Syndrome Treatment Revenue and Growth Rate (2012-2017)
        8.1.3 India Irritable Bowel Syndrome Treatment Sales Price Trend (2012-2017)
    8.2 India Irritable Bowel Syndrome Treatment Sales Volume and Market Share by Players
    8.3 India Irritable Bowel Syndrome Treatment Sales Volume and Market Share by Type
    8.4 India Irritable Bowel Syndrome Treatment Sales Volume and Market Share by Application

9 Global Irritable Bowel Syndrome Treatment Players/Suppliers Profiles and Sales Data
    9.1 Abbott Laboratories
        9.1.1 Company Basic Information, Manufacturing Base and Competitors
        9.1.2 Irritable Bowel Syndrome Treatment Product Category, Application and Specification
            9.1.2.1 Product A
            9.1.2.2 Product B
        9.1.3 Abbott Laboratories Irritable Bowel Syndrome Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
        9.1.4 Main Business/Business Overview
    9.2 Synergy Pharmaceuticals, Inc.
        9.2.1 Company Basic Information, Manufacturing Base and Competitors
        9.2.2 Irritable Bowel Syndrome Treatment Product Category, Application and Specification
            9.2.2.1 Product A
            9.2.2.2 Product B
        9.2.3 Synergy Pharmaceuticals, Inc. Irritable Bowel Syndrome Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
        9.2.4 Main Business/Business Overview
    9.3 Sucampo Pharmaceuticals, Inc.
        9.3.1 Company Basic Information, Manufacturing Base and Competitors
        9.3.2 Irritable Bowel Syndrome Treatment Product Category, Application and Specification
            9.3.2.1 Product A
            9.3.2.2 Product B
        9.3.3 Sucampo Pharmaceuticals, Inc. Irritable Bowel Syndrome Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
        9.3.4 Main Business/Business Overview
    9.4 Valeant Pharmaceuticals International, Inc.
        9.4.1 Company Basic Information, Manufacturing Base and Competitors
        9.4.2 Irritable Bowel Syndrome Treatment Product Category, Application and Specification
            9.4.2.1 Product A
            9.4.2.2 Product B
        9.4.3 Valeant Pharmaceuticals International, Inc. Irritable Bowel Syndrome Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
        9.4.4 Main Business/Business Overview
    9.5 Ardelyx, Inc.
        9.5.1 Company Basic Information, Manufacturing Base and Competitors
        9.5.2 Irritable Bowel Syndrome Treatment Product Category, Application and Specification
            9.5.2.1 Product A
            9.5.2.2 Product B
        9.5.3 Ardelyx, Inc. Irritable Bowel Syndrome Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
        9.5.4 Main Business/Business Overview
    9.6 Astellas Pharma Inc.
        9.6.1 Company Basic Information, Manufacturing Base and Competitors
        9.6.2 Irritable Bowel Syndrome Treatment Product Category, Application and Specification
            9.6.2.1 Product A
            9.6.2.2 Product B
        9.6.3 Astellas Pharma Inc. Irritable Bowel Syndrome Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
        9.6.4 Main Business/Business Overview
    9.7 Novartis AG
        9.7.1 Company Basic Information, Manufacturing Base and Competitors
        9.7.2 Irritable Bowel Syndrome Treatment Product Category, Application and Specification
            9.7.2.1 Product A
            9.7.2.2 Product B
        9.7.3 Novartis AG Irritable Bowel Syndrome Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
        9.7.4 Main Business/Business Overview
    9.8 GlaxoSmithKline plc.
        9.8.1 Company Basic Information, Manufacturing Base and Competitors
        9.8.2 Irritable Bowel Syndrome Treatment Product Category, Application and Specification
            9.8.2.1 Product A
            9.8.2.2 Product B
        9.8.3 GlaxoSmithKline plc. Irritable Bowel Syndrome Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
        9.8.4 Main Business/Business Overview
    9.9 Ironwood Pharmaceuticals, Inc.
        9.9.1 Company Basic Information, Manufacturing Base and Competitors
        9.9.2 Irritable Bowel Syndrome Treatment Product Category, Application and Specification
            9.9.2.1 Product A
            9.9.2.2 Product B
        9.9.3 Ironwood Pharmaceuticals, Inc. Irritable Bowel Syndrome Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
        9.9.4 Main Business/Business Overview

10 Irritable Bowel Syndrome Treatment Maufacturing Cost Analysis
    10.1 Irritable Bowel Syndrome Treatment Key Raw Materials Analysis
        10.1.1 Key Raw Materials
        10.1.2 Price Trend of Key Raw Materials
        10.1.3 Key Suppliers of Raw Materials
        10.1.4 Market Concentration Rate of Raw Materials
    10.2 Proportion of Manufacturing Cost Structure
        10.2.1 Raw Materials
        10.2.2 Labor Cost
        10.2.3 Manufacturing Process Analysis of Irritable Bowel Syndrome Treatment
    10.3 Manufacturing Process Analysis of Irritable Bowel Syndrome Treatment

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
    11.1 Irritable Bowel Syndrome Treatment Industrial Chain Analysis
    11.2 Upstream Raw Materials Sourcing
    11.3 Raw Materials Sources of Irritable Bowel Syndrome Treatment Major Manufacturers in 2016
    11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
    12.1 Marketing Channel
        12.1.1 Direct Marketing
        12.1.2 Indirect Marketing
        12.1.3 Marketing Channel Development Trend
    12.2 Market Positioning
        12.2.1 Pricing Strategy
        12.2.2 Brand Strategy
        12.2.3 Target Client
    12.3 Distributors/Traders List

13 Market Effect Factors Analysis
    13.1 Technology Progress/Risk
        13.1.1 Substitutes Threat
        13.1.2 Technology Progress in Related Industry
    13.2 Consumer Needs/Customer Preference Change
    13.3 Economic/Political Environmental Change

14 Global Irritable Bowel Syndrome Treatment Market Forecast (2017-2022)
    14.1 Global Irritable Bowel Syndrome Treatment Sales Volume, Revenue and Price Forecast (2017-2022)
       14.1.1 Global Irritable Bowel Syndrome Treatment Sales Volume and Growth Rate Forecast (2017-2022)
       14.1.2 Global Irritable Bowel Syndrome Treatment Revenue and Growth Rate Forecast (2017-2022)
       14.1.3 Global Irritable Bowel Syndrome Treatment Price and Trend Forecast (2017-2022)
    14.2 Global Irritable Bowel Syndrome Treatment Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
       14.2.1 Global Irritable Bowel Syndrome Treatment Sales Volume and Growth Rate Forecast by Regions (2017-2022)
       14.2.2 Global Irritable Bowel Syndrome Treatment Revenue and Growth Rate Forecast by Regions (2017-2022)
       14.2.3 United States Irritable Bowel Syndrome Treatment Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
       14.2.4 China Irritable Bowel Syndrome Treatment Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
       14.2.5 Europe Irritable Bowel Syndrome Treatment Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
       14.2.6 Japan Irritable Bowel Syndrome Treatment Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
       14.2.7 Southeast Asia Irritable Bowel Syndrome Treatment Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
       14.2.8 India Irritable Bowel Syndrome Treatment Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
    14.3 Global Irritable Bowel Syndrome Treatment Sales Volume, Revenue and Price Forecast by Type (2017-2022)
       14.3.1 Global Irritable Bowel Syndrome Treatment Sales Forecast by Type (2017-2022)
       14.3.2 Global Irritable Bowel Syndrome Treatment Revenue Forecast by Type (2017-2022)
       14.3.3 Global Irritable Bowel Syndrome Treatment Price Forecast by Type (2017-2022)
    14.4 Global Irritable Bowel Syndrome Treatment Sales Volume Forecas